nach oben

European Journal of Epidemiology

Erschienen in:

01.11.2012 | COMMENTARY

Next frontiers in the genetic epidemiology of Alzheimer’s disease

verfasst von: Mohammad Arfan Ikram, Charles DeCarli

Erschienen in: European Journal of Epidemiology | Ausgabe 11/2012

Einloggen, um Zugang zu erhalten

Excerpt

A recent report by Alzheimer Disease International showed that the number of persons suffering from Alzheimer’s disease will quadruple by 2050 (http://www.alz.co.uk/research/world-report-2011). This increase is predicted to occur globally and will likely pose a great societal burden, both in terms of financial costs as well as suffering for patients and care-givers [1]. Thus, there is a strong incentive to develop effective preventive and therapeutic strategies. In order to develop such strategies, full knowledge of the pathophysiology of Alzheimer’s disease is an essential first step. Similarly, identification of people at high risk of Alzheimer’s disease is equally important. Fully understanding the disease pathology and early detection methods would facilitate implementation of targeted interventions in those people, who would benefit from it most. …

Thies W, Bleiler L. 2011 Alzheimer’s disease facts and figures. Alzheimers Dement. 2011;7(2):208–44.PubMedCrossRef

Gatz M, Reynolds CA, Fratiglioni L, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63(2):168–74.PubMedCrossRef

Bertram L, Tanzi RE. The genetics of Alzheimer’s disease. Prog Mol Biol Transl Sci. 2012;107:79–100.PubMedCrossRef

Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90(5):1977–81.PubMedCrossRef

Hollingworth P, Harold D, Jones L, et al. Alzheimer’s disease genetics: current knowledge and future challenges. Int J Geriatr Psychiatry. 2011;26(8):793–802.PubMedCrossRef

Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am J Hum Genet. 2012;90(1):7–24.PubMedCrossRef

InternationalHapmapConsortium. The international HapMap project. Nature. 2003;426(6968):789–96.CrossRef

Coon KD, Myers AJ, Craig DW, et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer’s disease. J Clin Psychiatry. 2007;68(4):613–8.PubMedCrossRef

Grupe A, Abraham R, Li Y, et al. Evidence for novel susceptibility genes for late-onset Alzheimer’s disease from a genome-wide association study of putative functional variants. Hum Mol Genet. 2007;16(8):865–73.PubMedCrossRef

10.

Reiman EM, Webster JA, Myers AJ, et al. GAB2 alleles modify Alzheimer’s risk in APOE epsilon4 carriers. Neuron. 2007;54(5):713–20.PubMedCrossRef

11.

Ikram MA, Liu F, Oostra BA, et al. The GAB2 gene and the risk of Alzheimer’s disease: replication and meta-analysis. Biol Psychiatry. 2009;65(11):995–9.PubMedCrossRef

12.

Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet. 2009;41(10):1088–93.PubMedCrossRef

13.

Lambert JC, Heath S, Even G, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet. 2009;41(10):1094–9.PubMedCrossRef

14.

Psaty BM, Hofman A. Genome-wide association studies and large-scale collaborations in epidemiology. Eur J Epidemiol. 2010;25(8):525–9.

15.

Seshadri S, Fitzpatrick AL, Ikram MA, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010;303(18):1832–40.PubMedCrossRef

16.

Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nat Genet. 2011;43(5):429–35.PubMedCrossRef

17.

Naj AC, Jun G, Beecham GW, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. Nat Genet. 2011;43(5):436–41.PubMedCrossRef

18.

Morgan K. The three new pathways leading to Alzheimer’s disease. Neuropathol Appl Neurobiol. 2011;37(4):353–7.PubMedCrossRef

19.

Verhaaren BF, Vernooij MW, Koudstaal PJ, et al. Alzheimer’s disease genes and cognition in the nondemented general population. Biol Psychiatry. 2012. doi: 10.1016/j.biopsych.2012.04.009.

20.

Chen LH, Kao PY, Fan YH, et al. Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer’s disease in a southern Chinese population. Neurobiol Aging. 2012;33(1):210.e1–7.CrossRef

21.

Lee JH, Cheng R, Barral S, et al. Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol. 2011;68(3):320–8.PubMedCrossRef

22.

Logue MW, Schu M, Vardarajan BN, et al. A comprehensive genetic association study of Alzheimer disease in African Americans. Arch Neurol. 2011;68(12):1569–79.PubMedCrossRef

23.

Ferrari R, Hardy J, Momeni P. Frontotemporal dementia: from Mendelian genetics towards genome wide association studies. J Mol Neurosci. 2011;45(3):500–15.PubMedCrossRef

24.

Schrijvers EM, Schurmann B, Koudstaal PJ, et al. Genome-wide association study of vascular dementia. Stroke. 2012;43(2):315–9.PubMedCrossRef

25.

Van Deerlin VM, Sleiman PM, Martinez-Lage M, et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010;42(3):234–9.PubMedCrossRef

26.

Holliday EG, Maguire JM, Evans TJ, et al. Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet. 2012;44(10):1147–51.PubMedCrossRef

27.

Traylor M, Farrall M, Holliday EG, et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol. 2012;11(11):951–62.

28.

1000 Genome Project Consortium. A map of human genome variation from population-scale sequencing. Nature. 2010;467(7319):1061–73.CrossRef

29.

Holmes D. Mind the IGAP. Lancet Neurol. 2011;10(6):502–3.PubMedCrossRef

30.

Kiezun A, Garimella K, Do R, et al. Exome sequencing and the genetic basis of complex traits. Nat Genet. 2012;44(6):623–30.PubMedCrossRef

31.

Jonsson T, Atwal JK, Steinberg S, et al. A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline. Nature. 2012;488(7409):96–9.PubMedCrossRef

32.

Rucker JJ, McGuffin P. Genomic structural variation in psychiatric disorders. Dev Psychopathol. 2012;24(4):1335–44.PubMedCrossRef

33.

Brouwers N, Van Cauwenberghe C, Engelborghs S, et al. Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry. 2012;17(2):223–33.PubMedCrossRef

34.

Rovelet-Lecrux A, Legallic S, Wallon D, et al. A genome-wide study reveals rare CNVs exclusive to extreme phenotypes of Alzheimer disease. Eur J Hum Genet. 2012;20(6):613–7.PubMedCrossRef

35.

Lambert JC, Grenier-Boley B, Harold D, et al. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer’s disease. Mol Psychiatry. 2012. doi: 10.1038/mp.2012.14.

36.

Broer L, Koudstaal PJ, Amin N, Rivadeneira F, Uitterlinden AG, Hofman A, Oostra BA, Breteler MM, Ikram MA, van Duijn CM. Association of heat shock proteins with Parkinson’s disease. Eur J Epidemiol. 2011;26(12):933–5.

37.

Hu X, Pickering E, Liu YC, et al. Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer’s disease. PLoS ONE. 2011;6(2):e16616.PubMedCrossRef

38.

Yang J, Ferreira T, Morris AP, et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat Genet. 2012;44(4):369–75, S1–3.

39.

McQuillan R, Eklund N, Pirastu N, et al. Evidence of inbreeding depression on human height. PLoS Genet. 2012;8(7):e1002655.PubMedCrossRef

40.

Tan Q, Zhao JH, Li S, Kruse TA, Christensen K. Power assessment for genetic association study of human longevity using offspring of long-lived subjects. Eur J Epidemiol. 2010;25(7):501–6.

41.

Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 2010;9(1):119–28.PubMedCrossRef

42.

Gallo V, Egger M, McCormack V, Farmer PB, loannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P. STrengthening the reporting of observational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. Eur J Epidemiol. 2011;26(10):797–810.

43.

Ikram MA, van der Lugt A, Niessen WJ, et al. The Rotterdam Scan Study: design and update up to 2012. Eur J Epidemiol. 2011;26(10):811–24.PubMedCrossRef

44.

O’Donnell CJ, Kavousi M, Smith AV, et al. Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation. 2011;124(25):2855–64.PubMedCrossRef

45.

Ikram MA, Fornage M, Smith AV, et al. Common variants at 6q22 and 17q21 are associated with intracranial volume. Nat Genet. 2012;44(5):539–44.PubMedCrossRef

46.

Taal HR, St Pourcain B, Thiering E, et al. Common variants at 12q15 and 12q24 are associated with infant head circumference. Nat Genet. 2012;44(5):532–8.PubMedCrossRef

47.

Bis JC, DeCarli C, Smith AV, et al. Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet. 2012;44(5):545–51.PubMedCrossRef

48.

Stein JL, Medland SE, Vasquez AA, et al. Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet. 2012;44(5):552–61.PubMedCrossRef

49.

Fornage M, Debette S, Bis JC, et al. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol. 2011;69(6):928–39.PubMedCrossRef

50.

Zou F, Carrasquillo MM, Pankratz VS, et al. Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease. Neurology. 2010;74(6):480–6.PubMedCrossRef

51.

Ashburner J, Friston KJ. Voxel-based morphometry—the methods. Neuroimage. 2000;11(6 Pt 1):805–21.PubMedCrossRef

52.

Hibar DP, Stein JL, Kohannim O, et al. Voxelwise gene-wide association study (vGeneWAS): multivariate gene-based association testing in 731 elderly subjects. Neuroimage. 2011;56(4):1875–91.PubMedCrossRef

53.

Stein JL, Hua X, Lee S, et al. Voxelwise genome-wide association study (vGWAS). Neuroimage. 2010;53(3):1160–74.PubMedCrossRef

54.

Cuenco KT, Lunetta KL, Baldwin CT, et al. Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease. Arch Neurol. 2008;65(12):1640–8.CrossRef

Titel: Next frontiers in the genetic epidemiology of Alzheimer’s disease
verfasst von: Mohammad Arfan Ikram
Charles DeCarli
Publikationsdatum: 01.11.2012
Verlag: Springer Netherlands
Erschienen in: European Journal of Epidemiology / Ausgabe 11/2012
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI: https://doi.org/10.1007/s10654-012-9742-2

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2012

Erratum to: The IEA-EEF European Congress of Epidemiology 2012: Epidemiology for a Fair and Healthy Society

Mortality among participants and non-participants in a prospective cohort study

Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study

Survival from breast cancer in relation to access to tertiary healthcare, body mass index, tumor characteristics and treatment: a Hellenic Cooperative Oncology Group (HeCOG) study

Publication biases in probiotics

Socioeconomic inequalities in homicide mortality: a population-based comparative study of 12 European countries